Theratechnologies Inc. NASDAQ:THTX

Theratechnologies stock price today

$3.249
+1.45
+81.53%
Financial Health
0
1
2
3
4
5
6
7
8
9

Theratechnologies stock price monthly change

+24.31%
month

Theratechnologies stock price quarterly change

+24.31%
quarter

Theratechnologies stock price yearly change

+11.88%
year

Theratechnologies key metrics

Market Cap
85.98M
Enterprise value
119.66M
P/E
-1.65
EV/Sales
1.49
EV/EBITDA
-4.30
Price/Sales
0.95
Price/Book
-3.40
PEG ratio
0.03
EPS
-0.18
Revenue
82.40M
EBITDA
7.41M
Income
-6.95M
Revenue Q/Q
25.42%
Revenue Y/Y
3.40%
Profit margin
-59%
Oper. margin
-49.85%
Gross margin
67.17%
EBIT margin
-49.85%
EBITDA margin
9%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Theratechnologies stock price history

Theratechnologies stock forecast

Theratechnologies financial statements

Theratechnologies Inc. (NASDAQ:THTX): Profit margin
Aug 2023 20.85M -746K -3.58%
Nov 2023 23.45M -2.75M -11.75%
Feb 2024 16.08M -4.43M -27.58%
May 2024 22.01M 986.70K 4.48%
Theratechnologies Inc. (NASDAQ:THTX): Analyst Estimates
Aug 2025 24.5M -1.14M -4.69%
Aug 2025 25.55M 1.37M 5.4%
Aug 2025 24.5M -860.93K -3.51%
Nov 2025 26.85M 2.75M 10.27%
  • Analysts Price target

  • Financials & Ratios estimates

Theratechnologies Inc. (NASDAQ:THTX): Debt to assets
Aug 2023 56686000 98.39M 173.57%
Nov 2023 77769000 98.63M 126.84%
Feb 2024 71990966 96.55M 134.13%
May 2024 70204909 93.40M 133.05%
Theratechnologies Inc. (NASDAQ:THTX): Cash Flow
Aug 2023 5.32M 558K -7.91M
Nov 2023 -4.10M 142K 23.09M
Feb 2024 -1.69M 132.67K -272.27K
May 2024 -463.42K -135.15K -472.60K

Theratechnologies alternative data

Theratechnologies Inc. (NASDAQ:THTX): Employee count
Aug 2023 144
Sep 2023 144
Oct 2023 144
Nov 2023 144
Dec 2023 144
Jan 2024 144
Feb 2024 144
Mar 2024 103
Apr 2024 103
May 2024 103
Jun 2024 103
Jul 2024 103

Theratechnologies other data

6.75% -19.23%
of THTX is owned by hedge funds
6.42M -18.31M
shares is hold by hedge funds
Patent
Application
Filling date: 25 Jun 2021 Issue date: 21 Oct 2021
Application
Filling date: 22 Mar 2019 Issue date: 24 Sep 2020
Insider Compensation
Mr. Paul Lévesque (1964) Pres, Chief Executive Officer & Director
$861,830
Mr. Conor M. Walshe (1973) Gen. Mang. of Theratechnologies Europe Limited $370,510
Dr. Christian Marsolais (1963) Senior Vice President & Chief Medical Officer
$357,280
Mr. Philippe Dubuc M.B.A., MBA (1967) Senior Vice President & Chief Financial Officer
$318,540
Mr. Jocelyn Lafond (1968) Vice President of Legal Affairs & Corporation Sec.
$281,340
Wednesday, 18 December 2024
globenewswire.com
Tuesday, 10 December 2024
globenewswire.com
Monday, 9 December 2024
globenewswire.com
Wednesday, 4 December 2024
globenewswire.com
Tuesday, 3 December 2024
globenewswire.com
Monday, 2 December 2024
globenewswire.com
Tuesday, 26 November 2024
globenewswire.com
Thursday, 17 October 2024
globenewswire.com
globenewswire.com
Thursday, 10 October 2024
seekingalpha.com
globenewswire.com
Wednesday, 9 October 2024
globenewswire.com
Thursday, 26 September 2024
globenewswire.com
Tuesday, 17 September 2024
globenewswire.com
Monday, 9 September 2024
globenewswire.com
Thursday, 1 August 2024
zacks.com
Tuesday, 16 July 2024
zacks.com
Wednesday, 10 July 2024
globenewswire.com
Wednesday, 26 June 2024
globenewswire.com
Wednesday, 5 June 2024
zacks.com
Thursday, 23 May 2024
globenewswire.com
Thursday, 9 May 2024
globenewswire.com
Thursday, 2 May 2024
globenewswire.com
Tuesday, 23 April 2024
Zacks Investment Research
Thursday, 11 April 2024
GlobeNewsWire
Wednesday, 3 April 2024
GlobeNewsWire
Thursday, 28 March 2024
GlobeNewsWire
Monday, 26 February 2024
Zacks Investment Research
Tuesday, 6 February 2024
GlobeNewsWire
Thursday, 26 October 2023
InvestorPlace
  • What's the price of Theratechnologies stock today?

    One share of Theratechnologies stock can currently be purchased for approximately $3.25.

  • When is Theratechnologies's next earnings date?

    Unfortunately, Theratechnologies's (THTX) next earnings date is currently unknown.

  • Does Theratechnologies pay dividends?

    No, Theratechnologies does not pay dividends.

  • How much money does Theratechnologies make?

    Theratechnologies has a market capitalization of 85.98M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.13% to 81.76M US dollars.

  • What is Theratechnologies's stock symbol?

    Theratechnologies Inc. is traded on the NASDAQ under the ticker symbol "THTX".

  • What is Theratechnologies's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Theratechnologies?

    Shares of Theratechnologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Theratechnologies's key executives?

    Theratechnologies's management team includes the following people:

    • Mr. Paul Lévesque Pres, Chief Executive Officer & Director(age: 61, pay: $861,830)
    • Mr. Conor M. Walshe Gen. Mang. of Theratechnologies Europe Limited(age: 52, pay: $370,510)
    • Dr. Christian Marsolais Senior Vice President & Chief Medical Officer(age: 62, pay: $357,280)
    • Mr. Philippe Dubuc M.B.A., MBA Senior Vice President & Chief Financial Officer(age: 58, pay: $318,540)
    • Mr. Jocelyn Lafond Vice President of Legal Affairs & Corporation Sec.(age: 57, pay: $281,340)
  • How many employees does Theratechnologies have?

    As Jul 2024, Theratechnologies employs 103 workers.

  • When Theratechnologies went public?

    Theratechnologies Inc. is publicly traded company for more then 16 years since IPO on 13 Feb 2009.

  • What is Theratechnologies's official website?

    The official website for Theratechnologies is theratech.com.

  • Where are Theratechnologies's headquarters?

    Theratechnologies is headquartered at 2015 Peel Street, Montreal, QC.

  • How can i contact Theratechnologies?

    Theratechnologies's mailing address is 2015 Peel Street, Montreal, QC and company can be reached via phone at +1 514 336 7800.

Theratechnologies company profile:

Theratechnologies Inc.

theratech.com
Exchange:

NASDAQ

Full time employees:

103

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

2015 Peel Street
Montreal, QC H3A 1T8

CIK: 0001512717
ISIN: CA88338H7040
CUSIP: 88338H100